ODDB.org: Open Drug Database

Baxter AG - Caelyx, Konzentrat zur Herstellung einer Infusionslösung

Swissmedic Registration	54273	Sequence	01
Product name	Caelyx	Description	Konzentrat zur Herstellung einer Infusionslösung
ATC-Classification	L01DB01	ATC-Description	Doxorubicin
Introduction of Sequence	24.12.1997

Composition

doxorubicini hydrochloridum 2 mg, N-(carbonyl-methoxypolyethylenglycoli 2000)-1,2-distearoyl-sn-glycero-3-phosphoethanolaminum natricum, phosphatidylcholinum ex soja hydrogenatum, cholesterolum, ammonii sulfas, saccharum, histidinum, acidum hydrochloridum aut natrii hydroxidum, aqua ad iniectabile q.s. ad suspensionem pro 1 ml corresp. natrium 0.054 mg.

Packungsbestandteile

Galenic Form

Concentrate for infusion

Excipiens

Active Agent	Dose
Doxorubicin Hydrochloride	2 mg/ml

BAG: Active Agent	Dose
Doxorubicini Hydrochloridum, peg Liposomal	20 mg

Inactive agents
Acidum Hydrochloridum aut Natrii Hydroxidum
Ammonii Sulfas
Cholesterol
Histidine
N-(carbonyl-Methoxypolyethylenglycoli 2000)-1,2-distearoyl-Sn-Glycero-3-Phosphoethanolaminum Natricum
Phosphatidylcholinum ex soja Hydrogenatum
Saccharum

Package number	Package Size	EFP	CP	Category	SL	Out of trade (MedRef)
010	20 mg / 10 ml	232.38	283.45	A	SL	Yes

2024	©ywesee GmbH